bioAffinity Technologies, Inc. — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
This is a Form 10-Q quarterly report for bioAffinity Technologies, Inc. filed on 2026-08-07 for the period ending 2026-06-30. The filing documents are present (76 total files including XBRL data), but the specific financial metrics, operational results, revenue figures, losses, cash position, and material developments are not provided in the header/index text supplied. To assess materiality, actual P&L, balance sheet, cash flow, and MD&A sections would be required.
Why this rating
Routine quarterly disclosure. No material event, deal, financing, or restatement disclosed in filing index. Detailed metrics needed to evaluate.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.